Cyclosporine 0.05% Eye prep

Indications

Cyclosporine 0.05% Eye prep is used for: Dry eye

Adult Dose

Keratoconjuntivitis Sicca 1 drop twice daily approximately 12 hours apart in each eye May be used with artificial tears; allow 15-minute interval between products

Child Dose

<16 years Safety and efficacy not established >16 years Keratoconjuntivitis Sicca 1 drop twice daily approximately 12 hours apart in each eye May be used with artificial tears; allow 15-minute interval between products

Renal Dose

Administration

Contra Indications

Cyclosporine is contraindicated in patients with active ocular infections and in patients with known or suspected hypersensitivity to any of the ingredients in the formulation.

Precautions

Cyclosporine eye drop should not be administered while wearing contact lenses. Patients with decreased tear production typically should not wear contact lenses. If contact lenses are worn, they should be removed prior to the administration of this formulation. Lenses may be reinserted 15 minutes following administration of Cyclosporine eye drop. Lactation: Excretion in milk unknown; use with caution

Pregnancy-Lactation

Interactions

Increased ciclosporin level by diltiazem, doxycycline, erythromycin, ketoconazole, methylprednisolone (high doses), nicardipine, verapamil, oral contraceptives. Drugs which reduce ciclosporin level are carbamazepine, isoniazid, phenobarbitone, phenytoin and rifampicin. Increased risk of convulsion when used concurrently with high-dose methylprednisolone. Potentially Fatal: Additive nephrotoxicity when used with aminoglycosides, amphotericin B, ciprofloxacin, colchicine, melphalan, co-trimoxazole and NSAIDs.

Adverse Effects

Side effects of Cyclosporine 0.05% Eye prep : >10% Ocular burning (17%) Frequency Not Defined Conjunctival hyperemia,Discharge,Epiphora,Eye pain,Foreign body sensation,Pruritus

Mechanism of Action

Ciclosporin is a strong immunosuppressant that acts mainly on the helper T-cells. It inhibits the activation of calcineurin and production of interleukin-2, thus reducing cell-mediated immune response. May act as immunomodulator to suppress tear production in keratoconjunctivitis sicca